Frohlich Tom (CIK 1823925) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy JBIO (78,750 shares), Buy JBIO (6,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Jade Biosciences, Inc. (JBIO) | Chief Executive Officer | Buy | 78,750 | $0 |
| 2025-05-19 | Jade Biosciences, Inc. (JBIO) | Chief Executive Officer | Buy | 6,000 | $44,400 |
Source: SEC Form 4 filings · as of 2026-02-13